Contraception for cancer survivors

Eleanor Schwarz, Rachel Hess, James Trussell

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Women who have survived cancer may need guidance in choosing a method of contraception. This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonally mediated cancer. However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.

Original languageEnglish (US)
JournalJournal of General Internal Medicine
Volume24
Issue numberSUPPL. 2
DOIs
StatePublished - Nov 1 2009
Externally publishedYes

Fingerprint

Contraception
Survivors
Neoplasms
Copper Intrauterine Devices
Levonorgestrel
Intrauterine Devices
Tamoxifen
Contraceptive Agents
Tomography
Magnetic Resonance Imaging
Hormones
Safety

Keywords

  • Cancer survivors
  • Contraception

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Contraception for cancer survivors. / Schwarz, Eleanor; Hess, Rachel; Trussell, James.

In: Journal of General Internal Medicine, Vol. 24, No. SUPPL. 2, 01.11.2009.

Research output: Contribution to journalReview article

Schwarz, Eleanor ; Hess, Rachel ; Trussell, James. / Contraception for cancer survivors. In: Journal of General Internal Medicine. 2009 ; Vol. 24, No. SUPPL. 2.
@article{994c3014c5694857baf614b393c6777b,
title = "Contraception for cancer survivors",
abstract = "Women who have survived cancer may need guidance in choosing a method of contraception. This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonally mediated cancer. However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.",
keywords = "Cancer survivors, Contraception",
author = "Eleanor Schwarz and Rachel Hess and James Trussell",
year = "2009",
month = "11",
day = "1",
doi = "10.1007/s11606-009-1023-8",
language = "English (US)",
volume = "24",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Contraception for cancer survivors

AU - Schwarz, Eleanor

AU - Hess, Rachel

AU - Trussell, James

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Women who have survived cancer may need guidance in choosing a method of contraception. This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonally mediated cancer. However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.

AB - Women who have survived cancer may need guidance in choosing a method of contraception. This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonally mediated cancer. However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.

KW - Cancer survivors

KW - Contraception

UR - http://www.scopus.com/inward/record.url?scp=71949129210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949129210&partnerID=8YFLogxK

U2 - 10.1007/s11606-009-1023-8

DO - 10.1007/s11606-009-1023-8

M3 - Review article

C2 - 19838839

AN - SCOPUS:71949129210

VL - 24

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - SUPPL. 2

ER -